Loading…
CIK 0002092021 • 5 13F filings • Feb 26, 2026 – Aug 17, 2026
Import this data to Google Sheets with:
=jivedata("seven-fleet-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 3 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $1.8M | 1.2%Prev: 2.4% | 13,499 SH | Decreased-97,835 SH |
| ACLARIS THERAPEUTICS INC | COM | $323K | 0.2% | 107,419 SH | New |
| AGIOS PHARMACEUTICALS INC | COM | $864K | 0.6%Prev: 0.3% | 31,738 SH | Decreased-25,162 SH |
| ALX ONCOLOGY HLDGS INC | COM | $133K | 0.1% | 117,817 SH | New |
| AMICUS THERAPEUTICS INC | COM | $1.2M | 0.8% | 82,500 SH | New |
| AMYLYX PHARMACEUTICALS INC | COM | $140K | 0.1%Prev: 0.0% | 11,571 SH | Decreased-2,969 SH |
| APOGEE THERAPEUTICS INC | COM | $136K | 0.1% | 1,800 SH | New |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $1.2M | 0.8% | 5,670 SH | New |
| ASSEMBLY BIOSCIENCES INC | COM NEW | $2.5M | 1.7%Prev: 2.0% | 73,762 SH | Decreased-359,385 SH |
| ASTRIA THERAPEUTICS INC | COM | $52K | 0.0% | 4,000 SH | New |
| ATHIRA PHARMA INC | COM | $969K | 0.7% | 127,951 SH | New |
| AVALO THERAPEUTICS INC | COM NEW | $1.2M | 0.8%Prev: 2.4% | 63,343 SH | Decreased-707,422 SH |
| AXSOME THERAPEUTICS INC | COM | $2.4M | 1.6%Prev: 1.2% | 12,955 SH | Decreased-15,871 SH |
| BEAM THERAPEUTICS INC | COM | $264K | 0.2%Prev: 0.0% | 9,537 SH | Decreased+733 SH |
| BELITE BIO INC | SPONSORED ADS | $1.5M | 1.0% | 9,161 SH | New |
| CELCUITY INC | COM | $832K | 0.6%Prev: 0.3% | 8,338 SH | Decreased-7,914 SH |
| CG ONCOLOGY INC | COM | $62.9M | 42.6%Prev: 22.1% | 1,515,151 SH | Decreased-371,085 SH |
| CIDARA THERAPEUTICS INC | COM NEW | $668K | 0.5% | 3,026 SH | New |
| CLIMB BIO INC | COM | $306K | 0.2% | 76,400 SH | New |
| COGENT BIOSCIENCES INC | COM | $7.6M | 5.1%Prev: 0.9% | 214,099 SH | Increased+66,589 SH |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $276K | 0.2% | 40,000 SH | New |
| COMPASS THERAPEUTICS INC | COM | $3.1M | 2.1%Prev: 0.1% | 568,747 SH | Increased+335,681 SH |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $462K | 0.3%Prev: 0.0% | 56,750 SH | Increased+35,318 SH |
| CULLINAN THERAPEUTICS INC | COM | $31K | 0.0% | 3,000 SH | New |
| CYTOKINETICS INC | COM NEW | $657K | 0.4%Prev: 1.7% | 10,335 SH | Decreased-107,905 SH |
| CYTOMX THERAPEUTICS INC | COM | $208K | 0.1% | 48,898 SH | New |
| DIANTHUS THERAPEUTICS INC | COM | $604K | 0.4%Prev: 1.0% | 14,651 SH | Decreased-50,072 SH |
| DYNE THERAPEUTICS INC | COM | $1.4M | 0.9% | 70,180 SH | New |
| EDGEWISE THERAPEUTICS INC | COM | $50K | 0.0% | 2,000 SH | New |
| ELEDON PHARMACEUTICALS ORD | COM | $9K | 0.0% | 6,000 SH | New |
| ENANTA PHARMACEUTICALS INC | COM | $36K | 0.0% | 2,270 SH | New |
| ENLIVEN THERAPEUTICS INC | COM | $1.5M | 1.0%Prev: 3.1% | 99,953 SH | Decreased-265,433 SH |
| ENTERA BIO LTD | SHS | $263K | 0.2%Prev: 0.1% | 135,318 SH | Decreased-56,036 SH |
| EVOLUS INC | COM | $545K | 0.4%Prev: 0.1% | 82,000 SH | Increased+3,943 SH |
| EXELIXIS INC | COM | $3.0M | 2.0% | 68,569 SH | New |
| GENERATION BIO CO | COM NEW | $31K | 0.0% | 5,376 SH | New |
| GERON CORP | COM | $1.0M | 0.7%Prev: 0.2% | 777,880 SH | Decreased-279,348 SH |
| IMMUNIC INC | COM | $83K | 0.1% | 155,223 SH | New |
| INHIBIKASE THERAPEUTICS INC | COM NEW | $1.1M | 0.7%Prev: 0.1% | 533,648 SH | Increased+186,748 SH |
| KALVISTA PHARMACEUTICALS INC | COM | $782K | 0.5% | 48,412 SH | New |
| KRYSTAL BIOTECH INC | COM | $986K | 0.7%Prev: 0.1% | 4,000 SH | Increased+2,226 SH |
| LIQUIDIA CORPORATION | COM NEW | $3.1M | 2.1%Prev: 3.4% | 91,267 SH | Decreased-165,336 SH |
| MADRIGAL PHARMACEUTICALS INC | COM | $1.1M | 0.7%Prev: 0.4% | 1,860 SH | Decreased-3,113 SH |
| MBX BIOSCIENCES INC | COM | $574K | 0.4%Prev: 0.1% | 18,200 SH | Increased+12,200 SH |
| MINERALYS THERAPEUTICS INC | COM | $1.5M | 1.0% | 42,025 SH | New |
| MONTE ROSA THERAPEUTICS INC | COM | $63K | 0.0%Prev: 0.1% | 4,000 SH | Decreased-12,800 SH |
| NEKTAR THERAPEUTICS | COM NEW | $634K | 0.4% | 15,000 SH | New |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $140K | 0.1% | 4,000 SH | New |
| NURIX THERAPEUTICS INC | COM | $379K | 0.3% | 20,000 SH | New |
| NUVALENT INC | COM | $1.3M | 0.9% | 12,601 SH | New |
| OCULAR THERAPEUTIX INC | COM | $208K | 0.1% | 17,100 SH | New |
| ORUKA THERAPEUTICS INC | COM | $159K | 0.1% | 5,240 SH | New |
| PALISADE BIO INC | COM | $770K | 0.5%Prev: 0.1% | 327,500 SH | Increased+55,296 SH |
| PHARVARIS N V | COM | $1.5M | 1.0%Prev: 4.4% | 55,342 SH | Decreased-719,159 SH |
| PLIANT THERAPEUTICS INC | COM | $337K | 0.2% | 276,500 SH | New |
| PMV PHARMACEUTICALS INC | COM | $79K | 0.1%Prev: 0.0% | 63,498 SH | Increased+9,929 SH |
| PRAXIS PRECISION MEDICINES I | COM NEW | $796K | 0.5%Prev: 0.4% | 2,700 SH | Decreased-4,840 SH |
| PROTAGONIST THERAPEUTICS INC | COM | $699K | 0.5%Prev: 0.9% | 8,000 SH | Decreased-37,400 SH |
| PROTHENA CORP PLC | SHS | $414K | 0.3%Prev: 0.1% | 43,300 SH | Decreased |
| REGENCELL BIOSCIENCE HLDGS L | ORDINARY SHARES | $92K | 0.1% | 4,400 SH | New |
| RELAY THERAPEUTICS INC | COM | $618K | 0.4%Prev: 0.6% | 73,000 SH | Decreased-105,222 SH |
| RELMADA THERAPEUTICS INC | COM | $744K | 0.5%Prev: 0.4% | 154,109 SH | Decreased-194,156 SH |
| REVOLUTION MEDICINES INC | COM | $5.2M | 3.5%Prev: 7.5% | 65,800 SH | Decreased-176,229 SH |
| SAVARA INC | COM | $378K | 0.3%Prev: 0.3% | 62,762 SH | Decreased-246,341 SH |
| SEPTERNA INC | COM | $319K | 0.2% | 11,445 SH | New |
| SILENCE THERAPEUTICS PLC | ADS | $897K | 0.6%Prev: 0.1% | 147,600 SH | Increased+87,493 SH |
| SOLENO THERAPEUTICS INC | COM | $6.0M | 4.1% | 130,079 SH | New |
| TANGO THERAPEUTICS INC | COM | $1.9M | 1.3%Prev: 15.8% | 215,172 SH | Decreased-3,012,972 SH |
| TARSUS PHARMACEUTICALS INC | COM | $368K | 0.2%Prev: 1.3% | 4,500 SH | Decreased-112,567 SH |
| TAYSHA GENE THERAPIES INC | COM SHS | $920K | 0.6%Prev: 1.6% | 167,223 SH | Decreased-1,337,177 SH |
| TERNS PHARMACEUTICALS INC | COM | $5.3M | 3.6% | 130,413 SH | New |
| TRAWS PHARMA INC | COM NEW | $56K | 0.0% | 49,260 SH | New |
| TREVI THERAPEUTICS INC | COM | $89K | 0.1%Prev: 0.1% | 7,110 SH | Decreased-38,488 SH |
| TYRA BIOSCIENCES INC | COM | $2.1M | 1.4% | 79,560 SH | New |
| UNIQURE NV | SHS | $209K | 0.1%Prev: 0.0% | 8,742 SH | Increased+8,404 SH |
| UNITED THERAPEUTICS CORP DEL | COM | $633K | 0.4% | 1,300 SH | New |
| VAXCYTE INC | COM | $1.2M | 0.8%Prev: 0.3% | 25,365 SH | Decreased-4,435 SH |
| VERASTEM INC | COM NEW | $117K | 0.1% | 15,140 SH | New |
| VIKING THERAPEUTICS INC | COM | $211K | 0.1%Prev: 0.0% | 6,000 SH | Decreased-1,404 SH |
| VIR BIOTECHNOLOGY INC | COM | $1K | 0.0% | 200 SH | New |
| VIRIDIAN THERAPEUTICS INC | COM | $456K | 0.3% | 14,654 SH | New |
| VISTAGEN THERAPEUTICS INC | COM | $42K | 0.0% | 62,701 SH | New |
| XENCOR INC | COM | $1.7M | 1.1%Prev: 1.3% | 109,554 SH | Decreased-258,751 SH |
| ZURA BIO LTD | CLASS A ORD SHS | $872K | 0.6% | 166,500 SH | New |
| ZYMEWORKS INC | COM | $542K | 0.4% | 20,600 SH | New |
| 13F-HR/A |
| 0001013594-26-000652 |
| $318.3M |
| View |